Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | H3B-6527 |
| Trade Name | |
| Synonyms | H3B6527 |
| Drug Descriptions |
H3B-6527 selectively inhibits FGFR4, resulting in decreased downstream signaling and potentially leading to reduced tumor cell proliferation and tumor growth inhibition (PMID: 29247039, PMID: 31770593). |
| DrugClasses | FGFR4 Inhibitor 10 |
| CAS Registry Number | 1702259-66-2 |
| NCIT ID | C128862 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| H3B-6527 | H3B-6527 | 0 | 1 |
| H3B-6527 + Palbociclib | H3B-6527 Palbociclib | 0 | 0 |